| Amygdala volume |
Prognostic |
Parkinson’s disease |
G20, F02.3 |
|
| Ankle brachial index (ABI) |
Diagnostic |
Peripheral arterial disease |
I73 |
Used in clinic |
| Anterior temporal atrophy |
Diagnostic |
Frontotemporal lobar degeneration |
G31.0 |
|
| Carotid intima-media thickness (CIMT) |
Diagnostic |
Coronary disease |
I25.1 |
| Early hypertension |
Theragnostic |
Pancreatic cancer |
C25 |
Clinical trial |
| EBC pH |
Diagnostic |
Asthma |
J45 |
|
| Electrocardiography (ECG) |
Prognostic |
Acute coronary syndrome |
I20.0 |
| Hair morphology |
Prognostic; Theragnostic |
Mucopolysaccharidoses |
E76 |
| Hippocampal volume |
Prognostic |
Parkinson’s disease |
G20, F02.3 |
| Longitudinal MRI volumetric data |
Prognostic |
Alzheimer’s disease |
G30, F00 |
Used in clinic |
| Macrophage migration inhibitory factor (MIF) |
Diagnostic |
Bronchopulmonary dysplasia |
P27.1 |
|
| Mammographic density |
Diagnostic |
Breast cancer |
C50 |
Clinical trial |
| Mean width of frontal horns of lateral ventricles |
Prognostic |
Parkinson’s disease |
G20, F02.3 |
|
| Mean width of third ventricle |
Prognostic |
Parkinson’s disease |
G20, F02.3 |
| Motor unit number estimation |
Monitoring |
Amyotrophic lateral sclerosis |
G12.2 |
| Neurophysiological index |
Monitoring |
Amyotrophic lateral sclerosis |
G12.2 |
| Sclerosis |
Prognostic |
Follicular lymphoma |
C82 |
Clinical trial |
| Single-fiber electromyography (SFEMG) |
Prognostic |
Myasthenia gravis |
G70.0 |
|
| Sputum cytology |
Diagnostic |
Lung carcinoma |
C33-C34 |
| Total kidney volume (TKV) |
Prognostic |
Autosomal-Dominant Polycystic Kidney Disease |
Q61 |
| Unilateral area of substantia nigra hyperechogenicity |
Prognostic |
Parkinson’s disease |
G20, F02.3 |
| Urine osmolality |
Prognostic |
Autosomal-Dominant Polycystic Kidney Disease |
Q61 |
| Voxel-based morphometry |
Diagnostic |
Amyotrophic lateral sclerosis |
G12.2 |
